Skip to main content
SpringerLink
Log in

The effects of errors in lipid measurement and assessment

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Accurate cholesterol and lipoprotein measurements have provided dependable and powerful basic risk factors for cardiovascular disease. A battery of total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and triglycerides (TG) is recommended in the initial evaluation for classification of patients (based on lipids) into highly desirable, desirable, borderline, high, and very high lipid risk factor for cardiovascular disease. Treatment is based largely on the LDL cholesterol measurement result of the patient. The risk factor score of a patient greatly increases when other risk factors for cardiovascular disease exist, along with increased lipid risk factors. Attainment of the needed acceptable accurate lipid and lipoprotein measurements depends upon prevention or control of multiple sources of errors or variation that can exist in preanalytic, analytic, and postanalytic stages of determination of the reported result. Highly important is to control nonfasting, posture, diet, and alcohol intake in the preanalytic part, elimination of matrix effects and use of accurate calibrators in the analytic part, and check for transcription errors in preparation of reports in the postanalytic part of the measurement of lipids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cooper GR, Myers GL, Smith SJ, Schlant RC: Blood lipid measurements. Variations and practical utility. JAMA 1992, 267:1652–1660. A thorough discussion of sources of errors in lipid measurements and recommendation to physicians about how to calculate significance of biologic variation effect on the lipid result.

    Article  PubMed  CAS  Google Scholar 

  2. Rifai N, Dufour DR, Cooper GR: Preanalytical variation in lipid, lipoprotein, and apolipoprotein testing. In Handbook of Lipoprotein Testing, Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:161–187.

    Google Scholar 

  3. Smith SJ, Cooper GR, Myers GL, Sampson EJ: Biologic variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993, 39:1012–1022. Examination of results from 30 studies published during 1970 to 1992 to estimate the average intraindividual biologic variability for TC, LDL and HDL cholesterol, and TG in serum.

    PubMed  CAS  Google Scholar 

  4. Markel A, Brook JG, Aviram M: Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects. Postgrad Med J 1985, 61:395–400.

    Article  PubMed  CAS  Google Scholar 

  5. Wallentin L, Skoldstam L: Lipoproteins and cholesterol esterification rate in plasma during a 10-day modified fast in man. Am J Clin Nutr 1980, 33:1925–1931.

    PubMed  CAS  Google Scholar 

  6. Hagen RD, Upton SJV, Avakian EV, Grundy S: Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women. Prev Med 1986, 15:18–27.

    Article  Google Scholar 

  7. Miller M, Bachorik PS, Cloey TA: Normal variation of plasma lipoproteins postural effects on plasma concentrations of lipids, lipoproteins, and apolipoproteins. Clin Chem 1992, 38:569–574.

    PubMed  CAS  Google Scholar 

  8. Cooper GR, Sampson EJ, Smith SJ: Preanalytical, including biologic, variation in lipid and apolipoprotein measurements. Curr Opin Lipidol, 1992, 3:365–371.

    Article  CAS  Google Scholar 

  9. Cloey T, Bachorik PS, Becker D, et al.: Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA 1990, 263:2788–2789.

    Article  PubMed  CAS  Google Scholar 

  10. Beheshti I, Wessels LM, Eckfeldt JH: EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods. Clin Chem 1994, 40:2088–2092.

    PubMed  CAS  Google Scholar 

  11. Cohn JS, McNamara JR, Cohn SD, et al.: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988, 29:469–479.

    PubMed  CAS  Google Scholar 

  12. Romon M, Le Fur C, Lebel P, et al.: Circadian variation of postprandial lipemia. Am J Clin Nutr 1997, 65:934–940.

    PubMed  CAS  Google Scholar 

  13. Gore JM, Goldberg RJ, Matsumoto AS, et al.: Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984, 54:722–725. TC serum levels do not change within 24 hours after a myocardial infarction.

    Article  PubMed  CAS  Google Scholar 

  14. Haffner SM, Stern MP, Hazuda HP, et al.: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990, 263:2893–2898. Prediabetic subjects possess a pattern of atherosclerotic risk factors, especially hyperinsulinemia.

    Article  PubMed  CAS  Google Scholar 

  15. Despres J-P, Lamarche B, Mariege P, et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952–957.

    Article  PubMed  CAS  Google Scholar 

  16. Friis T, Pedersen LR: Serum lipids in hyper- and hypothyroidism before and after treatment. Clin Chem Acta 1987, 162:155–163.

    Article  CAS  Google Scholar 

  17. Alvarez C, Ramos A: Lipids, lipoproteins and apolipoproteins in serum during infection. Clin Chem 1986, 32:142–145.

    PubMed  CAS  Google Scholar 

  18. Bernert JT, Akins JR, Cooper GR, et al.: Factors influencing the accuracy of the National Reference System total cholesterol reference method. Clin Chem 1991, 37:2053–2061. The positive bias of the cholesterol reference method compared with the definitive method is caused by cholesterol precursors, phytosterols, and cholesterol oxidation products.

    PubMed  CAS  Google Scholar 

  19. Vanderlinde RE, Bowers GN Jr., Schaffer R, Edwards GC: The national reference system for cholesterol. Clin Lab Med 1989, 9:89–104.

    PubMed  CAS  Google Scholar 

  20. Miller WG: Matrix effects in the measurement and standardization of lipids and lipoproteins. In Handbook of Lipoprotein Testing, edn 2. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:695–716. A comprehensive report on matrix effects in the measurement of lipids and lipoproteins.

    Google Scholar 

  21. Myers GL, Waymack PP: Matrix effects in biological reference materials used in the standardization of cholesterol measurements. Fresenius J Anal Chem 1990, 338:538–542.

    Article  CAS  Google Scholar 

  22. National Cholesterol Education Program: Report from the Laboratory Standardization Panel. Recommendations for improving cholesterol measurement. NIH publication no. 90-2964. Bethesda, MD: National Institutes of Health; 1990:1–65.

    Google Scholar 

  23. National Committee for Clinical Laboratory Standards: Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures. C37. ANCCLS 1999, 19:1–26. The recommended serum pool preparation procedure decreases matrix effects and increases commutability among lipid methods.

    Google Scholar 

  24. National Cholesterol Education Program: A report from the Laboratory Standardization Panel: current status of blood cholesterol measurement in clinical laboratories in the United States. Clin Chem 1988, 34:193–201.

    Google Scholar 

  25. Myers GL, Kimberly MM, Waymack PP, et al.: A Reference Method Laboratory Network for Cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000, 46:1762–1772. This presents a model of how manufacturers of lipid diagnostic products can calibrate their analytic system accurately, and thus be able to distribute an accurately calibrated analytic system to clinical laboratories.

    PubMed  CAS  Google Scholar 

  26. Myers GL, Cooper GR, Greenberg N, et al.: Standardization of lipid and lipoprotein measurements. In Handbook of Lipoprotein Testing, end 2. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:717–748. This chapter details the CDC’s standardization activities and goals.

    Google Scholar 

  27. National Cholesterol Education Program: Executive summary of the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP 111). JAMA 2001, 285:2486–2496.

    Article  Google Scholar 

  28. D’Agostino RB, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham Coronary Heart Disease prediction scores. Results of a multiple ethnic groups investigation. JAMA 2001, 286:180–187.

    Article  PubMed  Google Scholar 

  29. Caudill SP, Cooper GR, Smith SJ, Myers GL: Assessment of current National Cholesterol Education Program guidelines for total cholesterol, triglyceride, HDL-cholesterol, and LDLcholesterol measurements. Clin Chem 1998, 44:1650–1658. Demonstrated that if a laboratory is meeting the NCEP analytic performance guidelines for bias and precision, the reported results are adequate to ensure correct patient risk classification. Joint probability statistical consideration includes association with two independent events.

    PubMed  CAS  Google Scholar 

  30. Li R, Bensen JT, Hutchinson RG, Province MA, et al.: Family risk score of coronary heart disease (CHD) as a predictor of CHD: The Atherosclerosis Risk in Communities(ARIC) Study and the NHLBI Family Heart Study. Genet Epidemiol 2000, 18:236–250.

    Article  PubMed  CAS  Google Scholar 

  31. Geberhiwot T, Jones AF, Bartlett WA, et al.: Laboratory-based calculation of coronary heart disease risk. Clin Chem 2001, 47:589–591.

    PubMed  CAS  Google Scholar 

  32. Lippi G, Arosi E, Prior M, Guidi G: Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology 2001, 52:681–687.

    Article  PubMed  CAS  Google Scholar 

  33. Rifai N, Ridker PM: Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001, 47:28–30.

    PubMed  CAS  Google Scholar 

  34. Cooper GR, Myers GL, Smith SJ, Sampson EJ: Standardization of lipid, lipoprotein and apolipoprotein measurements. Clin Chem 1988, 34(8B):B95-B105.

    PubMed  CAS  Google Scholar 

  35. Centers for Disease Control and Prevention: Cholesterol Reference Method Update. CDC manual. 1994, 1–25.

  36. Cooper GR, Myers GL, Henderson LO: Establishment of reference methods for lipids, lipoproteins and apolipoproteins. Eur J Clin Chem Clin Biochem 1991, 29:269–275.

    PubMed  CAS  Google Scholar 

  37. Bonino P, Plebani M, Ceriotti F, Rubboli F: Errors in laboratory medicine. Clin Chem 2002, 48:691–698.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway (F25), 30341, Atlanta, GA, USA

    Gerald R. Cooper MD, PhD

Authors
  1. Gerald R. Cooper MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary L. Myers PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary M. Kimberly PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parvin P. Waymack PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cooper, G.R., Myers, G.L., Kimberly, M.M. et al. The effects of errors in lipid measurement and assessment. Curr Cardiol Rep 4, 501–507 (2002). https://doi.org/10.1007/s11886-002-0114-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-002-0114-5

Keywords

Search

Navigation